Economic growth slowed sharply over the summer as supply-chain bottlenecks and the resurgent pandemic restrained activity at stores, factories and restaurants.
(CNN) -- A cheap, generically available anti-depressant may reduce the risk of severe COVID-19 disease by close to a third in people at high risk, researchers reported Wednesday.
The pandemic has killed over 700,000 Americans, but it has indirectly killed many more — all the people with treatable health emergencies who were unable to obtain care at hospitals overwhelmed with COVID patients.
Daily pediatric admissions with confirmed COVID have fallen 56% since the end of August to an average of about 0.2 per 100,000, according to HHS data. Among adults, new admissions fell 54% to 2.1 per 100,000 in the same period, the data show.
Moderna Inc. has emerged as a biotech power — and a household name — thanks to its success developing a COVID-19 vaccine. But that outcome hides what happened along the way: The company came perilously close to being the biggest loser in the race for a COVID-19 vaccine.